Seeing Is Believing
Healthcare - Sector
Genocea Biosciences's activity chart (see below) currently has 35 price targets and 33 ratings on display.
Analysts average stock forecasts to be materialized ratio is 29.17% with an average time for these price targets to be met of 75.05 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 29-Apr-2022. First documented stock forecast 05-Mar-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Apr-2022
$0.16
$0.16 (0.00%)
$13
4 years 6 months 3 days ago
(29-Apr-2022)
1/3 (33.33%)
$-0.12 (-42.86%)
25
Buy Since 08-Mar-2018
4 years 6 months 3 days ago
(29-Apr-2022)
0/3 (0%)
$5.4 (150.00%)
Buy Since 08-Jul-2019
$0.16
$0.16 (0.00%)
$13
4 years 6 months 3 days ago
(29-Apr-2022)
1/2 (50%)
$-0.12 (-42.86%)
25
Buy Since 15-Nov-2021
$6
$6 (0.00%)
$6
4 years 6 months 26 days ago
(06-Apr-2022)
0/2 (0%)
$4.74 (376.19%)
Buy Since 01-Mar-2019
$6
$6 (0.00%)
$7
5 years 8 months 21 days ago
(11-Feb-2021)
0/3 (0%)
$2.72 (82.93%)
What is GNCA (Genocea Biosciences) average time for price targets to be met?
Which analyst most recently updated their price target on GNCA (Genocea Biosciences)?
Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?
Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?
Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?